TickerFactsScreenerDevelopers

Avalo Therapeutics, Inc. (AVTX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $635.6K2018: $3.26M2019: -$566.5K2020: $300.0K2021: $1.49M2022: $3.43M2023: $1.28M$1.28M
2017Cost of Revenue (USD)2023
Fiscal YearCost of RevenueChange YoY
2023$1.28M-62.6%
2022$3.43M+130.3%
2021$1.49M+397.0%
2020$300.0K+153.0%
2019-$566.5K-117.4%
2018$3.26M+413.0%
2017$635.6K—